Erika Ruiz - Next Frontiers to Cure Cancer 2021

Erika Ruiz

Instituto Nacional de Cancerología

Actual Position
Professor of Gastrointestinal Medical Oncology Department & Chief of Translational Medicine
Laboratory. Instituto Nacional de Cancerologia, Mexico City, Mexico.
Professional Memberships
• Member of the National System of Researchers, National Council of Science and Technology
(CONACyT) from Mexico
• Member of the Southwest Oncology Group (SWOG)
• Faculty Member, Gastro-Intestinal Tumors, European Society for Medical Oncology
(ESMO).
• Member of the Scientific Committee, ESMO GI World Congress on Gastrointestinal Cancer
• Member of Gastrointestinal Cancer Guideline Advisory Group (ASCO)
• Guideline Panel Member for Adjuvant Therapy for Stage II and III Colon Cancer, for
Resource-Stratified Treatment of Invasive Colorectal Cancer Guideline Expert Panel and
for Rectal Cancer Guidelines (ASCO)
Honors
• Science and Technology Award in Food, National Council of Science and Technology –
(CONACyT) and Coca-Cola for “Methylation Landscape of Human Breast Cancer Cells in
Response to Dietary Compound Resveratrol”
• Oncology National Award, Sociedad Mexicana de Oncología, A.C., for “Antiproliferative
effects of the cannabinoid endogenous agonists on gastric cancer cells lines”
Personal Statement
I have published 62 peer-reviewed articles (on pubmed; H-factor: 19; 1012 citations) in prestigious
journals including, Journal of Clinical Oncology, European Journal of Cancer, British Journal of
Cancer and Scientific Reports. In addition, I have been a co-editor of the textbook Translational
Research and Onco-Omics Applications in the Era of Cancer Personal Genomics (Springer Nature
2019) and have been invited to serve as the Associated Editor of Frontiers Oncology section
Molecular and Cellular Oncology.

pt_BRPT_BR